tradingkey.logo
๎™ผ
tradingkey.logo
๎™๊ฒ€์ƒ‰
๎™

Ligand Pharmaceuticals Inc

LGND
๎˜ญ๊ด€์‹ฌ ๋ชฉ๋ก์— ์ถ”๊ฐ€
298.087USD
-2.443-0.81%
์‹œ์žฅ ์šด์˜ ์‹œ๊ฐ„ย ๏ผˆET๏ผ‰์‹œ์„ธ๋Š” 15๋ถ„ ์ง€์—ฐ๋ฉ๋‹ˆ๋‹ค
5.89B์‹œ๊ฐ€์ด์•ก
38.85P/E TTM

LGND ์žฌ๋ฌด ๋ฐ์ดํ„ฐ

์Šค๋งˆํŠธํ•œ ํˆฌ์ž์ž๋ฅผ ์œ„ํ•ด ์„ค๊ณ„๋œ ์˜ฌ์ธ์› ๋ฐ์ดํ„ฐ ๋Œ€์‹œ๋ณด๋“œ๋ฅผ ํ†ตํ•ด Ligand Pharmaceuticals Inc์˜ ์žฌ๋ฌด ๋ฐ์ดํ„ฐ๋ฅผ ํ™•์ธํ•˜์„ธ์š”. ๋ณต์žกํ•œ ์žฌ๋ฌด์ œํ‘œ๋ฅผ ์‚ฌ์šฉ์ž ์ •์˜ ๊ฐ€๋Šฅํ•œ ๋ทฐ๋กœ ๊ตฌ์„ฑํ•˜์—ฌ ์žฌ๋ฌด ๋ถ„์„์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. ์ตœ์‹  ์—ฐ๊ฐ„ ์žฌ๋ฌด ๋ณด๊ณ ์„œ์— ์ ‘๊ทผํ•˜๊ฑฐ๋‚˜, ์†์ต๊ณ„์‚ฐ์„œ, ์žฌ๋ฌด์ƒํƒœํ‘œ, ํ˜„๊ธˆ ํ๋ฆ„ํ‘œ๋ฅผ ์‚ฌ์šฉํ•˜์—ฌ ๋ถ„๊ธฐ๋ณ„ ์„ฑ๊ณผ๋ฅผ ๋ถ„์„ํ•˜์„ธ์š”. ์‹ค์‹œ๊ฐ„ ์žฌ๋ฌด ์ง€ํ‘œ๋ฅผ ์†๋์—์„œ ํ™•์ธํ•  ์ˆ˜ ์žˆ์–ด ํšŒ์‚ฌ์˜ ์‹œ์žฅ ๊ฑด์ „์„ฑ์„ ์‹œ๊ฐ„์— ๋”ฐ๋ผ ๊ทธ ์–ด๋А ๋•Œ๋ณด๋‹ค ์‰ฝ๊ฒŒ ๋ชจ๋‹ˆํ„ฐ๋งํ•  ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.

Ligand Pharmaceuticals Inc ์‹ค์  ๋ฐœํ‘œ์ผ

์ตœ์‹  ์ถœ์‹œ
Aug 6, 2026
EPS / ์˜ˆ์ƒ
--/1.87
์ˆ˜์ต / ์˜ˆ์ƒ
--/61.28M
์ฃผ๊ธฐ
FY2025 ์žฌ๋ฌด์ œํ‘œ
์ˆ˜์ต(YoY)
215.01M
28.65%
EPS(YoY)
6.13
2881.81%
์• ๋„๋ฆฌ์ŠคํŠธ ํ‰๊ฐ€
BUY
2026/07/27
๋ถ„๊ธฐ๋ณ„๎˜ฎ
๋ถ„๊ธฐ๋ณ„+์—ฐ๊ฐ„
๋ถ„๊ธฐ๋ณ„
์—ฐ๊ฐ„
YOY
๋นˆ ํ–‰ ์ˆจ๊ธฐ๊ธฐ
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
์žฌ๋ฌด ์ง€ํ‘œ
EPS
69.66%-0.67
234.71%2.21
1638.35%5.99
108.71%0.25
-145.54%-2.21
-273.88%-1.64
34.12%-0.39
-2272.37%-2.88
97.59%4.86
191.02%0.94
---0.59
--0.13
--2.46
---1.04
---1.23
----
----
----
----
----
์ˆ˜์ต
14.09%51.72M
39.37%59.67M
122.85%115.46M
14.68%47.63M
46.34%45.33M
52.35%42.81M
57.64%51.81M
57.52%41.53M
-29.56%30.98M
3.90%28.10M
-44.50%32.87M
-54.08%26.37M
20.44%43.98M
-62.68%27.05M
-8.66%59.22M
-32.19%57.42M
-33.79%36.52M
3.55%72.47M
54.93%64.83M
104.43%84.67M
์ˆœ์ด์ต
68.56%-13.35M
244.06%44.78M
1735.15%117.27M
109.34%4.85M
-149.28%-42.45M
-270.93%-31.09M
30.19%-7.17M
-2366.86%-51.91M
105.34%86.14M
204.02%18.19M
-2642.82%-10.27M
355.87%2.29M
372.66%41.95M
-222.84%-17.48M
-97.06%404.00K
-102.91%-895.00K
-184.97%-15.38M
-194.01%-5.42M
304.79%13.72M
39.12%30.73M
์ˆœ์ด์ต๋ฅ 
72.45%-25.80%
203.36%75.06%
833.76%101.57%
108.14%10.18%
-133.68%-93.64%
-212.19%-72.62%
55.71%-13.84%
-1539.12%-124.99%
180.39%278.07%
64.25%64.72%
---31.26%
--8.69%
--99.17%
--39.40%
--3.06%
----
----
----
----
----
์ด ์ด์ต๋ฅ 
9.74%78.02%
9.90%81.42%
13.06%89.70%
4.70%76.56%
10.61%71.09%
14.88%74.08%
23.32%79.33%
19.32%73.12%
-10.90%64.27%
221.14%64.49%
--64.33%
--61.28%
--72.13%
--20.08%
--60.98%
----
----
----
----
----
๋ถ€์ฑ„๋น„์œจ
1100607.92%29.17%
368849.42%28.59%
1201759.36%30.17%
82.01%0.00%
703.03%0.00%
134.85%0.01%
--0.00%
--0.00%
-100.00%0.00%
-99.97%0.00%
--0.00%
--0.00%
--9.47%
--10.06%
--7.30%
----
----
----
----
----
์ˆ˜์ต
14.09%51.72M
39.37%59.67M
122.85%115.46M
14.68%47.63M
46.34%45.33M
52.35%42.81M
57.64%51.81M
57.52%41.53M
-29.56%30.98M
3.90%28.10M
-44.50%32.87M
-54.08%26.37M
20.44%43.98M
-62.68%27.05M
-8.66%59.22M
-32.19%57.42M
-33.79%36.52M
3.55%72.47M
54.93%64.83M
104.43%84.67M
์˜์—… ์ด์ต
147.38%17.37M
1087.91%20.04M
-90.63%1.03M
31.51%9.72M
-1326.87%-36.66M
150.24%1.69M
1044.72%10.96M
472.72%7.39M
-78.97%2.99M
-127.58%-3.36M
-92.25%957.00K
-322.81%-1.98M
565.96%14.21M
-4.38%12.18M
-21.42%12.34M
-101.03%-469.00K
-54.76%2.13M
315.68%12.73M
319.16%15.71M
544.21%45.74M
์ˆœ์ด์ต
68.56%-13.35M
244.06%44.78M
1735.15%117.27M
109.34%4.85M
-149.28%-42.45M
-270.93%-31.09M
30.19%-7.17M
-2366.86%-51.91M
105.34%86.14M
204.02%18.19M
-2642.82%-10.27M
355.87%2.29M
372.66%41.95M
-222.84%-17.48M
-97.06%404.00K
-102.91%-895.00K
-184.97%-15.38M
-194.01%-5.42M
304.79%13.72M
39.12%30.73M
์œ ๋™์ž์‚ฐ
179.78%865.41M
151.02%832.27M
143.68%753.92M
13.03%352.94M
-16.15%309.32M
39.65%331.56M
21.81%309.39M
12.85%312.26M
12.41%368.91M
-9.93%237.43M
15.23%253.99M
13.51%276.71M
18.88%328.19M
-43.28%263.60M
-48.98%220.43M
-40.67%243.78M
-36.89%276.07M
-7.15%464.75M
-49.63%432.08M
-52.42%410.90M
์œ ๋™ ๋ถ€์ฑ„ ์ด๊ณ„
-30.70%40.67M
0.90%37.45M
23.28%30.54M
248.69%64.73M
229.35%58.68M
121.14%37.11M
57.51%24.77M
-36.83%18.57M
-81.99%17.82M
-83.02%16.78M
-88.37%15.73M
-82.49%29.39M
132.35%98.93M
137.15%98.81M
272.60%135.24M
219.74%167.85M
-55.56%42.58M
-58.38%41.66M
-14.19%36.30M
79.39%52.50M
์ด ์ž์‚ฐ
69.21%1.53B
65.71%1.56B
54.66%1.48B
9.49%948.60M
-0.92%905.43M
19.63%941.77M
24.13%954.87M
14.29%866.40M
12.67%913.87M
3.22%787.22M
-26.78%769.23M
-29.56%758.11M
-26.61%811.08M
-41.22%762.67M
-17.51%1.05B
-14.33%1.08B
-14.67%1.11B
-4.75%1.30B
2.10%1.27B
1.07%1.26B
๋ถ€์ฑ„ ์ด๊ณ„
386.60%534.78M
388.10%543.42M
363.20%526.60M
31.65%120.08M
2.38%109.90M
29.00%111.33M
12.20%113.69M
-2.15%91.21M
-34.85%107.35M
-47.75%86.30M
-56.75%101.33M
-65.97%93.21M
-47.19%164.76M
-65.33%165.18M
-49.24%234.31M
-41.69%273.92M
-43.20%311.99M
-27.01%476.43M
-16.02%461.59M
-14.27%469.77M
์ž๋ณธ ์ด๊ณ„
25.37%997.32M
22.49%1.02B
12.96%950.17M
6.88%828.53M
-1.36%795.53M
18.48%830.44M
25.94%841.18M
16.59%775.20M
24.79%806.52M
17.31%700.91M
-18.18%667.90M
-17.13%664.89M
-18.52%646.32M
-27.24%597.49M
0.52%816.30M
2.01%802.37M
6.35%793.19M
15.73%821.16M
16.37%812.07M
13.17%786.52M
์ˆœ์˜์—…์ด์ต
291.36%48.69M
61.27%45.91M
-64.17%13.09M
18.66%15.80M
-235.84%-25.45M
253.02%28.47M
377.77%36.53M
16336.59%13.31M
-44.82%18.73M
-84.92%8.06M
-62.68%7.65M
-100.69%-82.00K
-34.73%33.95M
93.44%53.47M
2.32%20.49M
-41.71%11.88M
383.64%52.01M
5047.49%27.64M
57.12%20.02M
-16.43%20.38M
์ˆœํˆฌ์ž
-2027.81%-94.35M
53.13%-18.10M
-659.98%-353.44M
80.52%-10.67M
229.64%4.89M
-275.56%-38.62M
-138.46%-46.51M
-824.71%-54.76M
-135.79%-3.77M
-41.19%-10.28M
-201.71%-19.50M
-80.04%7.56M
-90.74%10.55M
79.60%-7.28M
205.26%19.18M
95.73%37.85M
74.89%113.88M
90.66%-35.71M
-105.49%-18.22M
172.27%19.34M
์ˆœ์žฌ๋ฌดํ™œ๋™
-197.72%-14.13M
-59.14%8.33M
643.73%409.64M
57.99%14.99M
-138.97%-4.75M
283.59%20.39M
1584.40%55.08M
114.01%9.49M
1671.87%12.18M
200.32%5.32M
108.01%3.27M
-13.99%-67.76M
99.55%-775.00K
-227.23%-5.30M
-10504.94%-40.83M
-19.11%-59.44M
-85.98%-170.42M
115.13%4.16M
89.61%-385.00K
-998000.00%-49.91M

์ž์ฃผ ๋ฌป๋Š” ์งˆ๋ฌธ

Ligand Pharmaceuticals Inc์˜ ์ด์ˆ˜์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Ligand Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ๋งค์ถœ์€ 215.01M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 167.13M์ž…๋‹ˆ๋‹ค.

Ligand Pharmaceuticals Inc์˜ ์œ ๋™์ž์‚ฐ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Ligand Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์œ ๋™์ž์‚ฐ์€ 832.27M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 151.02์ž…๋‹ˆ๋‹ค.

Ligand Pharmaceuticals Inc์˜ ์ด์ž์‚ฐ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Ligand Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Ligand Pharmaceuticals Inc์˜ ์ด์ž์‚ฐ์€ 1.56B์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 65.71์ž…๋‹ˆ๋‹ค.

Ligand Pharmaceuticals Inc์˜ ์ด๋ถ€์ฑ„๋Š” ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Ligand Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Ligand Pharmaceuticals Inc์˜ ์ด๋ถ€์ฑ„๋Š” 543.42M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 388.10์ž…๋‹ˆ๋‹ค.

Ligand Pharmaceuticals Inc์˜ ์ด์ž๋ณธ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Ligand Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Ligand Pharmaceuticals Inc์˜ ์ด์ž๋ณธ์€ 1.02B์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 22.49์ž…๋‹ˆ๋‹ค.

Ligand Pharmaceuticals Inc์˜ ์ˆœ์˜์—…์†Œ๋“์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Ligand Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Ligand Pharmaceuticals Inc์˜ ์ˆœ์˜์—…์†Œ๋“์€ -1.27M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -105.53์ž…๋‹ˆ๋‹ค.

Ligand Pharmaceuticals Inc์˜ ์ˆœํˆฌ์ž๋Š” ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Ligand Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Ligand Pharmaceuticals Inc์˜ ์ˆœํˆฌ์ž๋Š” -377.32M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -162.64์ž…๋‹ˆ๋‹ค.

Ligand Pharmaceuticals Inc์˜ ์ˆœ์ž๊ธˆ์กฐ๋‹ฌ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Ligand Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Ligand Pharmaceuticals Inc์˜ ์ˆœ์ž๊ธˆ์กฐ๋‹ฌ์€ 428.22M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 340.83์ž…๋‹ˆ๋‹ค.

Ligand Pharmaceuticals Inc์˜ ์ฃผ๋‹น์ˆœ์ด์ต(EPS)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Ligand Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ฃผ๋‹น์ˆœ์ด์ต(EPS)์€ 6.13์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 2881.81์ž…๋‹ˆ๋‹ค.

Ligand Pharmaceuticals Inc์˜ ์ˆœ์ด์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Ligand Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ˆœ์ด์ต์€ 124.45M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 3186.63์ž…๋‹ˆ๋‹ค.

Ligand Pharmaceuticals Inc์˜ ์ˆœ์ด์ต๋ฅ ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Ligand Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ˆœ์ด์ต๋ฅ ์€ 57.88์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 2499.27์ž…๋‹ˆ๋‹ค.

Ligand Pharmaceuticals Inc์˜ ๋งค์ถœ์ด์ด์ต๋ฅ ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Ligand Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ๋งค์ถœ์ด์ด์ต๋ฅ ์€ 78.02์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 5.93์ž…๋‹ˆ๋‹ค.

Ligand Pharmaceuticals Inc์˜ ๋ถ€์ฑ„/์ž์‚ฐ ๋น„์œจ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Ligand Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ๋ถ€์ฑ„/์ž์‚ฐ ๋น„์œจ์€ 28.59์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 368849.42์ž…๋‹ˆ๋‹ค.

Ligand Pharmaceuticals Inc์˜ ์ž๊ธฐ์ž๋ณธ์ด์ต๋ฅ (ROE)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Ligand Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ž๊ธฐ์ž๋ณธ์ด์ต๋ฅ (ROE)์€ 13.47์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 2658.23์ž…๋‹ˆ๋‹ค.

Ligand Pharmaceuticals Inc์˜ ์ด์ž์‚ฐ์ด์ต๋ฅ (ROA)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Ligand Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ด์ž์‚ฐ์ด์ต๋ฅ (ROA)์€ 9.95์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 2232.65์ž…๋‹ˆ๋‹ค.

Ligand Pharmaceuticals Inc์˜ ์˜์—…์ด์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Ligand Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์˜์—…์ด์ต์€ -1.27M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -105.53์ž…๋‹ˆ๋‹ค.
tradingkey.logo
์œ„ํ—˜ ๊ฒฝ๊ณ : ์ €ํฌ ์›น์‚ฌ์ดํŠธ์™€ ๋ชจ๋ฐ”์ผ ์•ฑ์€ ํŠน์ • ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ผ๋ฐ˜์ ์ธ ์ •๋ณด๋งŒ์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. Finsights๋Š” ์žฌ์ •์  ์กฐ์–ธ์ด๋‚˜ ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜์ง€ ์•Š์œผ๋ฉฐ, ์ด๋Ÿฌํ•œ ์ •๋ณด ์ œ๊ณต์ด Finsights๊ฐ€ ๊ธˆ์œต ์กฐ์–ธ์ด๋‚˜ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜๋Š” ๊ฒƒ์œผ๋กœ ํ•ด์„๋˜์–ด์„œ๋Š” ์•ˆ ๋ฉ๋‹ˆ๋‹ค.
ํˆฌ์ž ์ƒํ’ˆ์€ ํˆฌ์ž ์›๊ธˆ ์†์‹ค์„ ํฌํ•จํ•œ ์ƒ๋‹นํ•œ ํˆฌ์ž ์œ„ํ—˜์— ๋…ธ์ถœ๋˜์–ด ์žˆ์œผ๋ฉฐ, ๋ชจ๋“  ์‚ฌ๋žŒ์—๊ฒŒ ์ ํ•ฉํ•˜์ง€ ์•Š์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค. ํˆฌ์ž ์ƒํ’ˆ์˜ ๊ณผ๊ฑฐ ์„ฑ๊ณผ๋Š” ๋ฏธ๋ž˜ ์„ฑ๊ณผ๋ฅผ ๋ณด์žฅํ•˜์ง€ ์•Š์Šต๋‹ˆ๋‹ค.
Finsights๋Š” ์ œ3์ž ๊ด‘๊ณ ์ฃผ๋‚˜ ์ œํœด์‚ฌ๊ฐ€ ์ €ํฌ ์›น์‚ฌ์ดํŠธ๋‚˜ ๋ชจ๋ฐ”์ผ ์•ฑ ๋˜๋Š” ๊ทธ ์ผ๋ถ€์— ๊ด‘๊ณ ๋ฅผ ๊ฒŒ์žฌํ•˜๊ฑฐ๋‚˜ ์ „๋‹ฌํ•  ์ˆ˜ ์žˆ๋„๋ก ํ—ˆ์šฉํ•  ์ˆ˜ ์žˆ์œผ๋ฉฐ, ์‚ฌ์šฉ์ž๊ฐ€ ๊ด‘๊ณ ์™€ ์ƒํ˜ธ์ž‘์šฉํ•˜๋Š” ๋ฐฉ์‹์— ๋”ฐ๋ผ ์ด๋“ค๋กœ๋ถ€ํ„ฐ ๋ณด์ƒ์„ ๋ฐ›์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.
ยฉ ์ €์ž‘๊ถŒ: FINSIGHTS MEDIA PTE. LTD. ๋ชจ๋“  ๊ถŒ๋ฆฌ ๋ณด์œ